InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
7
T+90 hit rate
65%
T+90 mean return
+3.8%
Across 23 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Fitzgerald Joseph Michael, Directeur Exécutif et Président. Insider active across 2 companies, notably Boston Scientific CORP. Aggregated, 46 disclosures have been published. Split: 1 buy · 7 sells. Total volume traded: €17.1m. History available since 6 May 2021. The latest transaction was disclosed on 17 November 2025 (C). Regulator: SEC (Form 4). The full history is free.
Declarations46 total
27,880 shares@ US$30.1950.0% of flowClass A Common StockSEC:0002036848-26-000004
27,880 shares@ US$30.190.30% mcap50.0% of flowClass A Common StockSEC:0002036848-26-000004:0
50,000 shares@ US$26.154.3% of flowCommon StockSEC:0001225208-25-008911:0
▼
3,600 shares@ US$100.74811.2% of flowCommon StockSEC:0001225208-25-008911:1
16,928 shares@ US$99.76075.6% of flowCommon StockSEC:0001225208-25-008911:2
29,472 shares@ US$99.14149.7% of flowCommon StockSEC:0001225208-25-008911:3
1,700 shares0Common StockSEC:0001225208-25-002471:0
1,000 shares0Common StockSEC:0001225208-25-002169:0
4,362 shares0Common StockSEC:0001225208-25-001870:0
3,462 shares0Common StockSEC:0001225208-25-001791:0
50 shares@ US$90.29190.0% of flowCommon StockSEC:0001225208-25-001683:0
Canonical exit: 3 Mar 2025 (T+90)
13,907 shares0Common StockSEC:0001225208-25-000204:0
1,113 shares0Common StockSEC:0001225208-24-010220:0
11,236 shares0Common StockSEC:0001225208-24-010220:1
59,021 shares@ US$17.263.5% of flowCommon StockSEC:0001225208-24-009233:0
57,618 shares@ US$24.985.0% of flowCommon StockSEC:0001225208-24-009233:1
132,527 shares@ US$85.000739.1% of flowCommon StockSEC:0001225208-24-009233:2
14,132 shares@ US$80.003.9% of flowCommon StockSEC:0001225208-24-008301:0
2,380 shares0Common StockSEC:0001225208-24-006005:0
67,974 shares@ US$66.2215.9% of flowCommon StockSEC:0001225208-24-002706:0
3,960 shares0Common StockSEC:0001225208-24-002575:0
4,362 shares0Common StockSEC:0001225208-24-002304:0
6,000 shares0Common StockSEC:0001225208-24-002042:0
33,332 shares0Common StockSEC:0001225208-24-001779:0
▼
11,660 shares@ US$60.002.4% of flowCommon StockSEC:0001225208-24-000922:0
25 of 46 declarations
About Fitzgerald Joseph Michael
Joseph Michael Fitzgerald is the Executive Vice President and President of Interventional Cardiology and Cardiology at Boston Scientific Corp. He oversees the operations of these divisions and is responsible for implementing growth strategies. His expertise in the medical sector contributes to innovation and treatment improvement. As a member of the management team, he plays a key role in the strategic direction of the organization's medical activities.
